Tag: Richard A. Gonzalez

AbbVie to acquire Cerevel Therapeutics for $8.7bn to expand neuroscience research

businessnewstoday- December 7, 2023

AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) have announced a definitive agreement in which AbbVie will acquire Cerevel Therapeutics. The transaction, valued at ... Read More

AbbVie to acquire ImmunoGen for $10.1bn to expand oncology portfolio

businessnewstoday- December 1, 2023

AbbVie Inc. and ImmunoGen Inc. have entered into a definitive agreement, marking a significant move in the pharmaceutical industry. AbbVie will acquire ImmunoGen, including its ... Read More

AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan

pharmanewsdaily- May 9, 2020

US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following receipt of all the required approvals from ... Read More